Angco, Alliyah Marly M.

HRN: 23-54-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
08/21/2023
08/28/2023
ORAL
3ml
Q12
PCAP
Waiting Final Action 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: